Quick Answer
Moleculin Biotech, Inc. reported Stockholders Equity of $15.01 million for fiscal year 2025.
Moleculin Biotech, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $15.01M | +33.9% |
| 2024 | $11.21M | -63.8% |
| 2023 | $30.93M | -40.7% |
| 2022 | $52.19M | -33.9% |
| 2021 | $78.99M | +344.8% |
| 2020 | $17.76M | +14.1% |
| 2019 | $15.57M | +9.1% |
| 2018 | $14.27M | -16.6% |
| 2017 | $17.12M | +14.4% |
| 2016 | $14.96M | +2108.1% |
| 2015 | -$745.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.92M | -254.6% | -650.9% |
| June 30, 2025 | -$3.58M | -118.5% | -126.0% |
| March 31, 2025 | $13.79M | -44.8% | +23.0% |
| December 31, 2024 | $11.21M | -63.8% | -35.6% |
| September 30, 2024 | $17.41M | -50.4% | -10.3% |
| June 30, 2024 | $19.41M | -51.8% | -22.3% |
| March 31, 2024 | $24.99M | -45.3% | -19.2% |
| December 31, 2023 | $30.93M | -40.7% | -12.0% |
- Moleculin Biotech, Inc. showed an increase of +33.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Moleculin Biotech, Inc.’s stockholders equity has grown by 2114.2% (from -$745.0 thousand to $15.01 million).
- The most recent figure is from Moleculin Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: